| Role |
Name |
Disclosure |
Details |
| Author | David R Haburchak, MD, Program Director, Professor, Department of Internal Medicine, Division of Infectious Disease, Medical College of Georgia | Nothing to disclose | Details | | Medical Editor | Pranatharthi Haran Chandrasekar, MD, Director of Infectious Disease Fellowship, Professor, Department of Internal Medicine, Harper Hospital, Wayne State University School of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Ronald A Greenfield, MD, Professor, Chief, Department of Internal Medicine, Section of Infectious Diseases, University of Oklahoma College of Medicine | Pfizer Gilead Ortho McNeil Wyeth Abbott Astellas Cubicin | Details | | CME Editor | Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital | Nothing to disclose | Details | | Chief Editor | Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital | Nothing to disclose | Details |
|